Research is core to the purpose of St George’s, and is a key part of our organisational strategy for 2019 – 2024. Through research, we play our part in developing the treatments of tomorrow, and the evidence shows that research-active organisations also attract high-quality staff, and that the pursuit of research positively impacts on the delivery of clinical care.
St George’s has a proud history in this field, and is increasingly active in research. We have seen a more than doubling of the number of our patients taking part in clinical trials since 2017, and more recently we have been amongst the top NHS Trusts in the country for the number of Covid clinical trials we are undertaking.
We have a strong partnership with the adjacent St. George’s, University of London, which helps to increase the impact of our research for the benefit our patients and the public.
A large number of our staff are actively involved in vital research studies, and many staff hold honorary appointments with St George’s University. We are committed to supporting our staff to lead research, and we have set up four specialist clinical academic groups and the Translational and Clinical Research Institute (TACRI) to further our research aims.
Increased funding from our local Clinical Research Network (CRN South London) and research funding bodies has brought substantial investment in our research infrastructure, including to our Clinical Research Facility who support our researchers to under their clinical trials and provide a supportive and safe environment for our patients.
We run clinical trials across all our clinical specialities, giving our patients the opportunity to participate in clinical trials. Patient and public involvement (involving patients in the planning and life-cycle of studies) remains a key element of our research strategy, and we continue to offer our patients access to the most innovative treatments available.
Associate Medical Director for Research
Professor Daniel Forton PhD FRCP